Genetic mutations recurrently identified in MDS patients lack the frequency and specificity required to serve as presumptive evidence of the disease, particularly due to high rate of CHIP defined by the same abnormalities in patients without a hematologic disorder. Here, STUB1 is linked to myelodysplastic syndrome.